–
Amylyx Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
19.2
FY23:
355
FY24:
81.4
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.7
FY22:
−201
FY23:
38.8
FY24:
−315
FY25:
−153
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−201
FY23:
39.9
FY24:
–
FY25:
−153
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.9
FY22:
−198
FY23:
54.3
FY24:
−302
FY25:
−145
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.9
FY22:
−198
FY23:
49.3
FY24:
−302
FY25:
−145
All amounts in millions USD